Relevant Interviews, Disease and Trial Updates and Stock-Markets News posted by CRISPR Medicine News.
Always stay updated with the free CMN Newsletter.
Genome editing tool: CRISPR-Cas9
Funding stage: Private
Location: Dublin, Ireland
Partners: Sumitomo Pharma
ERS Genomics is founded by Nobel prize winner Emanuelle Charpentier, and holds multiple patents to the CRISPR-Cas9 technology. The company has provided non-exclusive licenses for the use of CRISPR-Cas9 to many companies worldwide, although many remain undisclosed.